The Long COVID-19 Wearable Device Study
Scripps Translational Science Institute
100,500 participants
Nov 16, 2023
INTERVENTIONAL
Conditions
Summary
To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.
Eligibility
Inclusion Criteria11
- Is at least 18 years old.
- Has a self/and or physician diagnosis of:
- Long COVID (based on the WHO working definition),
- ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or
- POTS (Postural Orthostatic Tachycardia Syndrome).
- Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms.
- Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one.
- Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly.
- Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback.
- Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies.
- Agrees to complete at least 75% of the study surveys.
Exclusion Criteria1
- As long as they meet inclusion there is no exclusion
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The treatment group will receive their wearable device and the enhanced education at the start of the study. Their outcomes will be compared with the control group who will receive at 3 months.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05741112